StockData
Cytosorbents Corp logo

Cytosorbents Corp (CTSO) stock

CTSONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 2/30
$5.57+1.05 (+23.12%)

Close on Nov 18, 2026Market cap $349.72MP/E –Yield –

Cytosorbents shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Cytosorbents's shares outstanding was 63M at Jun 30, 2026. For fiscal 2025 it was 62M, up 14.3% from the year before. Over ten years it grew 9.6% a year on average. The highest annual figure on record is 62M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202562M+14.3%
FY2024Dec 31, 202454M+21.9%
FY2023Dec 31, 202345M+2.5%
FY2022Dec 31, 202244M+0.5%
FY2021Dec 31, 202143M+11.7%
FY2020Dec 31, 202039M+20.3%
FY2019Dec 31, 201932M+5.0%
FY2018Dec 31, 201831M+11.2%
FY2017Dec 31, 201728M+8.6%
FY2016Dec 31, 201625M+2.2%
FY2015Dec 31, 201525M+73.0%
FY2014Dec 31, 201414M+52.3%
FY2013Dec 31, 20139M+19.1%
FY2012Dec 31, 20128M+23.7%
FY2011Dec 31, 20116M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202663M-6.5%
Q1 FY2026Mar 31, 202663M+3.3%
Q4 FY2025Dec 31, 202563M+14.8%
Q3 FY2025Sep 30, 202563M+15.2%
Q2 FY2025Jun 30, 202567M+23.7%
Q1 FY2025Mar 31, 202561M+11.6%
Q4 FY2024Dec 31, 202455M+17.5%
Q3 FY2024Sep 30, 202454M+22.7%
Q2 FY2024Jun 30, 202454M+23.4%
Q1 FY2024Mar 31, 202454M+24.6%
Q4 FY2023Dec 31, 202347M+6.7%
Q3 FY2023Sep 30, 202344M+1.8%
Q2 FY2023Jun 30, 202344M+1.0%
Q1 FY2023Mar 31, 202344M+0.4%
Q4 FY2022Dec 31, 202244M+0.4%
Q3 FY2022Sep 30, 202244M+0.5%
Q2 FY2022Jun 30, 202244M+0.6%
Q1 FY2022Mar 31, 202243M+0.4%
Q4 FY2021Dec 31, 202143M+0.6%
Q3 FY2021Sep 30, 202143M+4.3%
Q2 FY2021Jun 30, 202143M+18.7%
Q1 FY2021Mar 31, 202143M+27.5%
Q4 FY2020Dec 31, 202043M+33.2%
Q3 FY2020Sep 30, 202042M+28.5%
Q2 FY2020Jun 30, 202036M+13.1%
Q1 FY2020Mar 31, 202034M+6.4%
Q4 FY2019Dec 31, 201932M+2.4%
Q3 FY2019Sep 30, 201932M+3.4%
Q2 FY2019Jun 30, 201932M+6.5%
Q1 FY2019Mar 31, 201932M+8.8%
Q4 FY2018Dec 31, 201832M+10.2%
Q3 FY2018Sep 30, 201831M+11.0%
Q2 FY2018Jun 30, 201830M+8.4%
Q1 FY2018Mar 31, 201829M+15.1%
Q4 FY2017Dec 31, 201729M+12.9%
Q3 FY2017Sep 30, 201728M+10.9%
Q2 FY2017Jun 30, 201728M–
Q1 FY2017Mar 31, 201726M–
Q4 FY2016Dec 31, 201625M–
Q3 FY2016Sep 30, 201625M–

More Cytosorbents figures

See a number that looks wrong?